Osteoporose – Langzeitmanagement einer chronischen Erkrankung

Dagmar Wildpaner; Chiara Pavese; Marcel Weber

doi:10.1024/1661-8157/a002651

Osteoporose – Langzeitmanagement einer chronischen Erkrankung

Praxis (Bern 1994). 2017 Apr;106(8):421-427. doi: 10.1024/1661-8157/a002651.

[Article in German]

Authors

Dagmar Wildpaner¹, Chiara Pavese¹, Marcel Weber¹

Affiliation

¹ 1 Klinik für Rheumatologie, Stadtspital Triemli, Zürich.

PMID: 28401777
DOI: 10.1024/1661-8157/a002651

No abstract available

Keywords: Bisphosphonate; Denosumab; Langzeitbehandlung; Osteoporose; Osteoporosis; Ostéoporose; bisphosphonates; denosumab; long-term therapy; traitement à long terme.

Publication types

Review

MeSH terms

Absorptiometry, Photon
Adult
Aged
Aged, 80 and over
Bone Density Conservation Agents / adverse effects
Bone Density Conservation Agents / therapeutic use
Combined Modality Therapy
Denosumab / adverse effects
Denosumab / therapeutic use
Diphosphonates / adverse effects
Diphosphonates / therapeutic use
Early Diagnosis
Early Medical Intervention
Female
Guideline Adherence
Humans
Long-Term Care
Male
Middle Aged
Osteoporosis, Postmenopausal / diagnosis
Osteoporosis, Postmenopausal / drug therapy*
Osteoporotic Fractures / diagnosis
Osteoporotic Fractures / prevention & control*
Risk Factors

Substances

Bone Density Conservation Agents
Diphosphonates
Denosumab